Abe, Mary Jane .

HRN: 05-05-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2025
CEFUROXIME 500MG (TAB)
10/15/2025
10/22/2025
PO
500
Bid
Nsvd Rmle
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines